Characteristic | Cycle 3 2005/2006 (n = 16,382) | Cycle 4 2007/2008 (n = 18,424) | Cycle 5 2009/2010 (n = 18,048) | Total Cohort (n = 52,854) |
---|---|---|---|---|
Sex, n, (%) female | 9184 (56.1) | 10,212 (55.4) | 10,197 (56.5) | 29,593 (56.0) |
Age Group, years, n (%) | ||||
 45–54 | 4548 (27.8) | 4996 (27.1) | 4437 (24.6) | 13,981 (26.5) |
 55–64 | 4900 (29.9) | 5619 (30.5) | 5515 (30.6) | 16,034 (30.3) |
 65–74 | 3794 (23.2) | 4212 (22.9) | 4282 (23.7) | 12,288 (23.2) |
 75+ | 3140 (19.2) | 3597 (19.5) | 3814 (21.1) | 10,551 (20.0) |
Level of Multimorbidity, n (%) | ||||
 0 | 4124 (25.2) | 4655 (25.3) | 4427 (24.5) | 13,206 (25.0) |
 1 | 4727 (28.9) | 5253 (28.5) | 5047 (28.0) | 15,027 (28.4) |
 2 | 3734 (22.8) | 4205 (22.8) | 4064 (22.5) | 12,003 (22.7) |
 3 | 2133 (13.0) | 2463 (13.4) | 2553 (14.1) | 7149 (13.5) |
 4+ | 1664 (10.2) | 1848 (10.0) | 1957 (10.8) | 5469 (10.3) |
Functional Limitations, n (%) | 2457 (15.0) | 3013 (16.4) | 2968 (16.4) | 8438 (16.0) |